Reports
Sale
Global Chlorpheniramine Maleate Market Size, Trends, Growth: By Dosage Form: Tablet, Syrup, Eye Drops, Injection; By Application: Allergy, Common Cold, Hay Fever, Rhinitis, Others; By End User: Hospitals, Clinics, Homecare Settings, Others; By Distribution Channel: Hospital Pharmacies, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Chlorpheniramine Maleate Market Outlook
The global chlorpheniramine maleate market size was valued at USD 514.9 million in 2023, driven by the increased prevalence of allergic conditions across the globe. The market is expected to grow at a CAGR of 5.7% during the forecast period of 2024-2032, with the values likely to rise from USD 544.3 million in 2024 to USD 848.1 million by 2032.
Global Chlorpheniramine Maleate Market Overview
Chlorpheniramine maleate, an antihistamine, is commonly used to relieve symptoms like watery eyes, cough, runny nose, and rash from allergies, common cold, and hay fever. The medication manages the symptoms by blocking histamine, a chemical released during an allergic reaction. Heightened public awareness regarding allergy management and the availability of over the counter chlorpheniramine maleate products drives the market demand for the antihistamine.
The rising prevalence of allergic conditions such as allergic rhinitis or seasonal allergies has led to a higher demand for antihistamines like chlorpheniramine maleate. According to recent data, the prevalence of allergic rhinitis is estimated to fall in the range of 5% to 50%, with the incidence rate high in childhood until early adulthood. Further, in the United States, the condition is very common, with population studies suggesting a prevalence of 20-30% in adults and around 40% in children. This increasing prevalence of allergies is expected to bolster chlorpheniramine maleate market growth in the coming years.
In September 2023 , a United States-based pharmaceutical company, Dr. Ferrer Biopharma, shared the results of its product Intranasal Chlorpheniramine Maleate (iCPM) from two randomized controlled trials (ACCROS I and ACCROS III) at the European Respiratory Society (ERS) Congress 2023, revealing the potential of the intranasal chlorpheniramine to treat prolonged post-COVID 19 symptoms. The data from the trials highlighted the antiviral and anti-inflammatory effects of iCPM reduced post-COVID symptoms by over 90% compared to a placebo. This continued research on chlorpheniramine maleate products by the key market players is expected to increase demand and market growth for this medication.
Other factors that influence the chlorpheniramine maleate market value include improvements in healthcare infrastructure, increased access to emerging economies, and the efficacy of the medication to address a wide range of symptoms during an allergic reaction. Moreover, with the rising advancements in formulation technology, new chlorpheniramine maleate products with better efficiency and fewer side effects are anticipated to enter the market.
Global Chlorpheniramine Maleate Market Trends
| Key Trend | Impact |
| Growing Over-the-Counter (OTC) Medication Market | The expansion of the over-the-counter medication market, driven by consumer preference for self-medication and convenience, significantly impacts the chlorpheniramine maleate market demand. As a result, chlorpheniramine maleate products are witnessing increased sales in OTC allergy and cold formulations. Further, the availability of these medications without a prescription attracts a huge consumer base, propelling market growth. |
| Advancements in Drug Formulation | The market is experiencing technological advancements in drug formulation and delivery systems that are likely to accelerate the development of chlorpheniramine maleate products with improved efficacy and reduced side effects. Innovations such as extended-release tablets and combination products are increasingly used to provide symptomatic relief for multiple conditions such as allergies and colds. |
| Robust Network of Distribution Channels | The expansion of distribution channels, including online pharmacies and e-commerce platforms, has made chlorpheniramine maleate more accessible to the growing patient base. This ease of access, along with the convenience of home delivery, is likely to augment the chlorpheniramine maleate market share. However, stringent quality control and regulatory oversight are needed for such distribution platforms to prevent the distribution of substandard products and ensure patient safety. |
| Global Expansion into Emerging Markets | With healthcare infrastructure improving in emerging economies, there is a growing opportunity for chlorpheniramine maleate to expand its footprint. Greater access to medications, healthcare awareness, and rising disposable incomes contribute to higher demand for allergy treatments. Chlorpheniramine maleate, with its established efficacy and affordability, is anticipated to witness high demand in such developing markets. |
Global Chlorpheniramine Maleate Market Segmentation
Market Breakup by Dosage Form
- Tablet
- Syrup
- Eye Drops
- Injection
The market is divided by dosage form into tablets, syrup, eye drops, and injection forms. This market segment offers various options for administration based on patient needs and preferences.
Market Breakup by Application
- Allergy
- Common Cold
- Hay Fever
- Rhinitis
- Others
In terms of application, chlorpheniramine maleate is used to manage symptoms of allergies, common colds, hay fever, and rhinitis, among others. The utility of this market segment is reflected in the use of chlorpheniramine maleate to address a wide range of symptoms associated with these conditions.
Market Breakup by End User
- Hospitals
- Clinics
- Homecare Settings
- Others
End-users of chlorpheniramine maleate products include hospitals, clinics, and homecare settings, among others. These healthcare facilities provide treatment for allergies and related conditions.
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- Online Pharmacies
Distribution channels for the chlorpheniramine maleate market includes hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. This diverse network of distribution channels ensures accessibility and convenience for patients to obtain these medications.
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
On the basis of region, chlorpheniramine maleate market share includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The prevalence of allergies, advancement in the healthcare infrastructure, and the regulatory landscape are some factors that influence the market dynamics in different regional markets. North America leads the market segment which can be attributed to the rising prevalence of allergies and greater accessibility to healthcare services. Further, the robust ongoing research to develop safer and more effective allergy medications led by the key market players is expected to propel the market growth in the region.
Global Chlorpheniramine Maleate Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Sun Pharmaceutical Industries Ltd.
- Novalab Healthcare Pvt. Ltd
- Bayer AG
- GlaxoSmithKline PLC
- Salvidas Pharmaceuticals Pvt. Ltd
- Orion Life Science
- Viatris Inc.
- Ataby Pharmaceuticals
- Johnson & Johnson
- Zydus Lifesciences Limited
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Dosage Form |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Queries Solved in the Global Chlorpheniramine Maleate Market Report
- How will the market landscape evolve in the coming years?
- What are the major market trends influencing the market?
- What are the major drivers, opportunities, and restraints in the market?
- What will be the effect of each driver, challenge, and opportunity on the market?
- Which region is poised to lead the market share in the forecast period?
- Which region is expected to experience expedited growth during the forecast period?
- Which dosage form is expected to experience a significant demand in the market segment?
- Which application is poised to make the highest impact on the chlorpheniramine maleate market size?
- Which distribution channel is expected to dominate the respective market segment?
- Which end user will contribute significantly to the market growth in the coming years?
- What are the key research initiatives expected to boost the market size during the forecast period?
- What are the market shares, strategies, and product portfolios of the leading players in the market?
- How is the regulatory landscape impacting market growth?
- Which segment has the highest impact on the market size?
- How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics of the electrophoresis equipment industry?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Chlorpheniramine Maleate Market Overview
3.1 Global Chlorpheniramine Maleate Market Historical Value (2017-2023)
3.2 Global Chlorpheniramine Maleate Market Forecast Value (2024-2032)
4 Global Chlorpheniramine Maleate Market Landscape*
4.1 Global Chlorpheniramine Maleate: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Chlorpheniramine Maleate: Product Landscape
4.2.1 Analysis by Dosage Form
4.2.2 Analysis by Applications
5 Global Chlorpheniramine Maleate Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Chlorpheniramine Maleate Market Segmentation (2017-2032)
6.1 Global Chlorpheniramine Maleate Market (2017-2032) by Dosage Form
6.1.1 Market Overview
6.1.2 Tablet
6.1.3 Syrup
6.1.4 Eye Drops
6.1.5 Injection
6.2 Global Chlorpheniramine Maleate Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Allergy
6.2.3 Common Cold
6.2.4 Hay Fever
6.2.5 Rhinitis
6.2.6 Others
6.3 Global Chlorpheniramine Maleate Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Homecare Settings
6.3.5 Others
6.4 Global Chlorpheniramine Maleate Market (2017-2032) by Distribution Channel
6.4.1 Market Overview
6.4.2 Hospital Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Drug Store
6.4.5 Online Pharmacies
6.5 Global Chlorpheniramine Maleate Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Chlorpheniramine Maleate Market (2017-2032)
7.1 North America Chlorpheniramine Maleate Market (2017-2032) by Dosage Form
7.1.1 Market Overview
7.1.2 Tablet
7.1.3 Syrup
7.1.4 Eye Drops
7.1.5 Injection
7.2 North America Chlorpheniramine Maleate Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Allergy
7.2.3 Common Cold
7.2.4 Hay Fever
7.2.5 Rhinitis
7.2.6 Others
7.3 North America Chlorpheniramine Maleate Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Chlorpheniramine Maleate Market (2017-2032)
8.1 Europe Chlorpheniramine Maleate Market (2017-2032) by Dosage Form
8.1.1 Market Overview
8.1.2 Tablet
8.1.3 Syrup
8.1.4 Eye Drops
8.1.5 Injection
8.2 Europe Chlorpheniramine Maleate Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Allergy
8.2.3 Common Cold
8.2.4 Hay Fever
8.2.5 Rhinitis
8.2.6 Others
8.3 Europe Chlorpheniramine Maleate Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Chlorpheniramine Maleate Market (2017-2032)
9.1 Asia Pacific Chlorpheniramine Maleate Market (2017-2032) by Dosage Form
9.1.1 Market Overview
9.1.2 Tablet
9.1.3 Syrup
9.1.4 Eye Drops
9.1.5 Injection
9.2 Asia Pacific Chlorpheniramine Maleate Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Allergy
9.2.3 Common Cold
9.2.4 Hay Fever
9.2.5 Rhinitis
9.2.6 Others
9.3 Asia Pacific Chlorpheniramine Maleate Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Chlorpheniramine Maleate Market (2017-2032)
10.1 Latin America Chlorpheniramine Maleate Market (2017-2032) by Dosage Form
10.1.1 Market Overview
10.1.2 Tablet
10.1.3 Syrup
10.1.4 Eye Drops
10.1.5 Injection
10.2 Latin America Chlorpheniramine Maleate Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Allergy
10.2.3 Common Cold
10.2.4 Hay Fever
10.2.5 Rhinitis
10.2.6 Others
10.3 Latin America Chlorpheniramine Maleate Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Chlorpheniramine Maleate Market (2017-2032)
11.1 Middle East and Africa Chlorpheniramine Maleate Market (2017-2032) by Dosage Form
11.1.1 Market Overview
11.1.2 Tablet
11.1.3 Syrup
11.1.4 Eye Drops
11.1.5 Injection
11.2 Middle East and Africa Chlorpheniramine Maleate Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Allergy
11.2.3 Common Cold
11.2.4 Hay Fever
11.2.5 Rhinitis
11.2.6 Others
11.3 Middle East and Africa Chlorpheniramine Maleate Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Sun Pharmaceutical Industries Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Novalab Healthcare Pvt. Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bayer AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 GlaxoSmithKline PLC
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Salvidas Pharmaceuticals Pvt. Ltd
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Orion Life Science
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Viatris Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Ataby Pharmaceuticals
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Johnson & Johnson
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Zydus Lifesciences Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Chlorpheniramine Maleate Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 514.9 million in 2023 driven by the increased prevalence of allergic conditions across the globe.
The market is anticipated to grow at a CAGR of 5.70% during the forecast period of 2024-2032, likely to reach a market value of USD 848.1 million by 2032.
The market demand is driven by heightened public awareness regarding allergy management and the availability of over the counter chlorpheniramine maleate products.
One of the significant trends is the continued innovations of chlorpheniramine maleate products by the key market players. In September 2023, a United States-based pharmaceutical company, Dr. Ferrer Biopharma, shared the results of its product Intranasal Chlorpheniramine Maleate (iCPM) to treat prolonged post-COVID 19 symptoms.
Based on the dosage form, the market is segmented into tablets, syrup, eye drops, and injection forms.
Major end users of the market include hospitals, clinics, and homecare settings, among others.
Applications of chlorpheniramine maleate include managing symptoms of allergies, common colds, hay fever, and rhinitis, among others.
Distribution channels for the market include hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Sun Pharmaceutical Industries Ltd., Novalab Healthcare Pvt. Ltd, Bayer AG, GlaxoSmithKline PLC, Salvidas Pharmaceuticals Pvt. Ltd, Orion Life Science, Viatris Inc., Ataby Pharmaceuticals, Johnson & Johnson, and Zydus Lifesciences Limited.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER